SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Ella Fitzgerald — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientElla Fitzgerald
Date of birth1917-04-25
IdentifiersMRN HR-ML029-SYN-TD; SSN (made up) 000-29-3640
Document date1987-05-11
AuthorOdessa Whitlow, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit: diabetes with calf pain on walking, low glucose after late shows, eye and foot examinations, and cardiovascular risk [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1970sDiabetes affecting her eyes, with health problems beginning in the 1970sD (CLM-0007)
1970sCataract surgery, after which she returned to touring more than 40 weeks a yearD (CLM-0008)
1986Intensive care admission for heart trouble and quintuple-bypass heart surgeryD (CLM-0009)

Family History

RelativeConditionAge at deathEvidence
motherDied suddenly of a heart attack in 1932; age at death not recorded in the cited sourceD (CLM-0002)

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1000 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with breakfast and the evening mealOral route1977-03-01activeS
Glipizide 10 mg oral tablet, one tablet by mouth twice daily before mealsOne tablet by mouth twice daily before breakfast and the evening mealOral route1982-09-01 to 1987-05-11completedS
Insulin glargine 100 units/mL pen, 30 units under the skin at bedtime30 units at bedtimeSubcutaneous route1984-04-01 to 1987-05-11completedS
Insulin glargine 100 units/mL pen, 24 units under the skin each morning24 units each morning, at the same clock time on tour, with written time-zone adjustmentsSubcutaneous route1987-05-11activeS
Atorvastatin 40 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1986-06-02 to 1987-05-11completedS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1987-05-11activeS
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1986-06-02activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1986-06-02activeS
Empagliflozin 10 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning; hold on days she cannot eat or drink normally and before surgeryOral route1987-05-11activeS
Glucagon 3 mg nasal powder, one spray into one nostril for a severe low glucoseOne spray into one nostril if she cannot safely swallow during a low glucose; may repeat once after 15 minutes with a new device; call 911Nasal route1987-05-11activeS

Review of Systems

Positive for the concerns in the history of present illness. Alert, warm, and engaged; worried about her legs and her eyes and determined to keep performing. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. Independent in all activities of daily living; walks about one and a half blocks before calf pain stops her; uses a wheelchair in large airports; stands through 75-minute sets. [S]

Physical Exam

Vital signs recorded on 1987-05-11; see the Vital Signs section. Mental status: Alert, warm, and engaged; worried about her legs and her eyes and determined to keep performing. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Vital Signs

DateMeasureValueUnitProvenance
1987-05-11Body height165cmS
1987-05-11Body weight84kgS
1987-05-11Body mass index (BMI) [Ratio]30.9kg/m2S
1987-05-11Systolic blood pressure126mm[Hg]S
1987-05-11Diastolic blood pressure70mm[Hg]S
1987-05-11Heart rate62/minS
1987-05-11Respiratory rate16/minS
1987-05-11Body temperature36.6CelS
1987-05-11Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1987-05-11Hemoglobin A1c/Hemoglobin.total in Blood8.6%Below 5.7% is normal; her individualized goal is below 7.5%HighS
1987-05-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1987-05-11Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
1987-05-11Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
1987-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1982)/1.73 sq M67mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1987-05-11Glucose [Mass/volume] in Serum or Plasma168mg/dL70-99 mg/dLHighS
1987-05-11Albumin/Creatinine [Mass Ratio] in Urine18mg/g<=30 mg/gNormalS
1987-05-11Cholesterol [Mass/volume] in Serum or Plasma164mg/dL<=199 mg/dLNormalS
1987-05-11Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation92mg/dLHer goal with coronary and peripheral artery disease is below 55 mg/dLNormalS
1987-05-11Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=50 mg/dLLowS
1987-05-11Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
1987-05-11Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-35 U/LNormalS
1987-05-11Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L10-35 U/LNormalS
1987-05-11Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
1987-05-11Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma386pg/mL232-1245 pg/mLNormalS
1987-05-11Ankle-brachial index0.62{ratio}1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormalLowS
1987-05-11Ankle-brachial index0.74{ratio}1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormalLowS
1987-05-11Toe brachial index - right0.46{ratio}Above 0.70 normalLowS
1987-05-11Toe brachial index - left0.55{ratio}Above 0.70 normalLowS
1987-05-11Visual acuity best corrected Right eye by ETDRS eye chart64{letters}85 letters is about 20/20; 80 about 20/25; 65 about 20/50LowS
1987-05-11Visual acuity best corrected Left eye by ETDRS eye chart81{letters}85 letters is about 20/20; 80 about 20/25; 65 about 20/50NormalS

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes mellitus with peripheral artery disease: cramping in both calves after about one and a half blocks of walking, worse on the right, easing within minutes of rest; no rest pain, wounds, or color change. Resting ankle-brachial index 0.62 right and 0.74 left, toe-brachial index 0.46 and 0.55; dorsalis pedis and posterior tibial pulses absent on the right and faint on the left. A1c 8.6% on metformin, glipizide and glargine, with low glucose readings (to 52 mg/dL) after late performances. Foot: protective sensation intact to the 10-g monofilament at all sites and to vibration; callus under the second metatarsal heads; hammer toes of the second and third toes; no ulcer (IWGDF risk category 2). Synthetic modern episode linked to her documented diabetes and its circulatory complicationsactiveconfirmed E11.51S — Synthetic modern diagnosis; the type of diabetes was not made public and is synthetic.
Moderate nonproliferative diabetic retinopathy with center-involving diabetic macular edema in the right eye (best-corrected acuity 64 letters, about 20/50) and moderate nonproliferative retinopathy without macular edema in the left eye (81 letters); lens implants in both eyes from earlier cataract surgery. Synthetic modern episode linked to her documented diabetic eye problemsactiveconfirmed E11.3311S — Synthetic modern eye diagnosis on retinal imaging and optical coherence tomography in the clinic; the left eye is described in the display.
Coronary artery disease after five-vessel coronary bypass surgery last year, with an intensive care stay; no angina now; on aspirin, a statin, and metoprolol. Synthetic modern episode linked to her documented heart surgeryactiveconfirmed I25.10S — Synthetic modern coding of her documented heart surgery; bypass grafts are described in the display.

Assessment

Plan of Treatment